Type of Study: Clinical Trial

Sponsor / Support: LACOG / GBECAM

Primary Objectives: To evaluate in a phase III randomized clinical trial the comparison between an anthracycline-initiated neoadjuvant chemotherapy regimen (AC-T) versus a taxane-initiated regimen (T-AC) in patients with locally advanced HER2- breast cancer

Design: Phase III, open-label, multicenter randomized clinical trial

Sample Size: 494 patients

Principal Investigator: José Bines

Countries LATAM: Brazil

Clinicaltrials.gov Identifier: NCT04540692

Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil (LACOG 0221)

Prospective evaluation of breast cancer at Brazilian institutions – Project AMAZONA III Type of Study: Epidemiological Sponsor